Systemic treatment with the inhibitory neurotransmitter gamma-aminobutyric acid aggravates experimental autoimmune encephalomyelitis by affecting proinflammatory immune responses. Carmans S, Hendriks JJA, Slaets H, Thewissen K, Stinissen P, Rigo J-M, Hellings N J Neuroimmunol. 2012 Nov 26. PMID: 23194644. Abstract CommentRecommendBookmarkWatch